NovoCure NVCR Germany — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's germany — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's germany — net revenues?
- NovoCure (NVCR) reported germany — net revenues of $24.5M in Q1 2026.
- How has NovoCure's germany — net revenues changed year-over-year?
- NovoCure's germany — net revenues increased by 30.9% year-over-year, from $18.72M to $24.5M.
- What is the long-term trend for NovoCure's germany — net revenues?
- Over 4 years (2021 to 2025), NovoCure's germany — net revenues has grown at a -4.1% compound annual growth rate (CAGR), from $93.94M to $79.41M.
- What does germany — net revenues mean?
- This metric represents the total gross sales generated from the sale of medical devices and related services within the German geographic market, net of returns and allowances. It serves as a key indicator of the company's commercial penetration and market adoption of its therapeutic technologies in this specific region. Tracking this figure helps investors assess regional growth trends and the effectiveness of local sales and reimbursement strategies.